Yann P.
- Country
- France
- Department
- Centre de référence pour les maladies neuromusculaires, Hôtel-Dieu
Research Overview
- Efficacy of Rituximab Versus Placebo in Anti-MAG Neuropathy Patients with Predicted Good Response: A Randomized Controlled Trial
- Efficacy and Safety of DYNE-101 in Participants with Myotonic Dystrophy Type 1: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
- Phase 3 Study of Delpacibart Zotadirsen in Duchenne Muscular Dystrophy with Mutations Amenable to Exon 44 Skipping
Data & Insights
Has run more than one trial at 49 of 110 partner sites.
Specializations
Muscular Dystrophies
The investigator specializes in various forms of muscular dystrophy, focusing on Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy, and Myotonic Dystrophy Type 1. Their research encompasses innovative therapeutic approaches for these progressive muscle disorders.
- Novel gene therapy applications
- Muscle function improvement strategies
- Long-term treatment outcomes
Neuromuscular Disorders
Their expertise extends to various neuromuscular conditions, including Myasthenia Gravis and Charcot-Marie-Tooth Disease. The investigator evaluates novel therapeutic compounds targeting these specific neurological conditions.
- Autoimmune neuromuscular junction disorders
- Peripheral nerve diseases
- Clinical efficacy assessments
Neuropathies
The investigator studies complex neurological conditions including paraneoplastic sensory neuropathy and chronic inflammatory demyelinating polyneuropathy. Their work involves immunotherapy approaches and long-term treatment strategies.
- Immunological interventions
- Autoimmune neuropathies
- Novel therapeutic formulations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.